<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01926275</url>
  </required_header>
  <id_info>
    <org_study_id>GZIRD-201308</org_study_id>
    <nct_id>NCT01926275</nct_id>
  </id_info>
  <brief_title>NPPV Added Inspiratory Muscle Training in Severe COPD</brief_title>
  <official_title>Noninvasive Positive Pressure Ventilation Added Inspiratory Muscle Training in Severe Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou Institute of Respiratory Disease</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou Institute of Respiratory Disease</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine whether noninvasive positive pressure ventilation with
      inspiratory muscle training can improve quality of life and respiratory muscle strength than
      noninvasive positive pressure ventilation or inspiratory muscle training alone.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Change from Baseline in quality of life at 8 weeks</time_frame>
    <description>Severe Respiratory Insufficiency (SRI) Questionnaire and chronic obstructive pulmonary disease assessment test(CAT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>respiratory muscle strength</measure>
    <time_frame>Change from Baseline in respiratory muscle strength at 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>Change from Baseline in dyspnea at 8 weeks</time_frame>
    <description>baseline dyspnea index (BDI)and transition dyspnea index(TDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walked distance in 6MWT</measure>
    <time_frame>Change from Baseline in walked distance at 8 weeks</time_frame>
    <description>Change from baseline in distance walked test 6-minute walk test at 8 week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of acute exacerbations of COPD</measure>
    <time_frame>8 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function tests</measure>
    <time_frame>Change from Baseline in pulmonary function tests at 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood gases levels</measure>
    <time_frame>Change from Baseline in blood gases levelsat 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>Change from Baseline in sleep qualityat 8 weeks</time_frame>
    <description>Epworth´s Sleepiness Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital admission</measure>
    <time_frame>8 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of of hospital admission</measure>
    <time_frame>8 week</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Hypercapnic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>NPPV+IMT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>noninvasive positive pressure ventilation and inspiratory muscle training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NPPV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>noninvasive positive pressure ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>inspiratory muscle training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LTOT</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Long time oxygen therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NPPV+IMT</intervention_name>
    <description>noninvasive positive pressure ventilation and inspiratory muscle training</description>
    <arm_group_label>NPPV</arm_group_label>
    <arm_group_label>IMT</arm_group_label>
    <arm_group_label>LTOT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NPPV</intervention_name>
    <description>noninvasive positive pressure ventilation</description>
    <arm_group_label>NPPV+IMT</arm_group_label>
    <arm_group_label>IMT</arm_group_label>
    <arm_group_label>LTOT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IMT</intervention_name>
    <description>inspiratory muscle training</description>
    <arm_group_label>NPPV+IMT</arm_group_label>
    <arm_group_label>NPPV</arm_group_label>
    <arm_group_label>LTOT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 40-75 years, male or female.

          2. Have spirometric evidence of COPD with an FEV1 of &lt; 50% predicted and FEV1/FVC &lt; 0.70,
             measured within the last 6 months (GOLD stage III and IV). Stable disease since 4
             weeks or more prior to randomisation.

          3. PCO2 of 7 kPa, combined with a pH of 7.35 or above. These gases must be measured after
             30 minutes breathing room air in sitting position

          4. No treatment with NPPV and respiratory muscle training in the last 8 weeks

        Exclusion Criteria:

          1. Smokers can be excluded;

          2. Diseases of the lung or thorax besides COPD: OSA Advanced pulmonary fibrosis, advanced
             bronchiectases, active tuberculosis, post tuberculosis syndrome, pneumonia, severe
             kyphoscoliosis, tracheostoma, neuromuscular diseases, or any other disorder, which
             might result in elevated PCO2

          3. Body mass index of 35 kg/m² or above. Severe cardiac disease, NYHA IV, instable
             angina, severe cardiac arrhythmia, especially of ventricular origin (atrial
             fibrillation is not an exclusion criterion).

          4. Local derangement of the face, skin, tongue, upper airways, larynx and upper
             oesophagus.

          5. Severe chronic diseases except COPD, hindering the patient to follow the schedule of
             this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LuQian Zhou, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangzhou Institute of Respiratory Disease</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>LuQian Zhou, Doctor</last_name>
    <phone>+86-15622236759</phone>
    <email>zhlx09@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangzhou Institute of Respiratory Disease</name>
      <address>
        <city>Canton</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LuQian Zhou, Doctor</last_name>
      <phone>+86-15622236759</phone>
      <email>zhlx09@163.com</email>
    </contact>
    <investigator>
      <last_name>LuQian Zhou, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2013</study_first_submitted>
  <study_first_submitted_qc>August 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2013</study_first_posted>
  <last_update_submitted>August 18, 2013</last_update_submitted>
  <last_update_submitted_qc>August 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou Institute of Respiratory Disease</investigator_affiliation>
    <investigator_full_name>LuQian Zhou</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Noninvasive Positive Pressure Ventilation</keyword>
  <keyword>Respiratory Muscle Training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

